Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding

Neuropilins (Nrps) are co‐receptors for class 3 semaphorins and vascular endothelial growth factors and important for the development of the nervous system and the vasculature. The extracellular portion of Nrp is composed of two domains that are essential for semaphorin binding (a1a2), two domains n...

Full description

Saved in:
Bibliographic Details
Published inThe EMBO journal Vol. 26; no. 23; pp. 4902 - 4912
Main Authors Appleton, Brent A, Wu, Ping, Maloney, Janice, Yin, JianPing, Liang, Wei-Ching, Stawicki, Scott, Mortara, Kyle, Bowman, Krista K, Elliott, J Michael, Desmarais, William, Bazan, J Fernando, Bagri, Anil, Tessier-Lavigne, Marc, Koch, Alexander W, Wu, Yan, Watts, Ryan J, Wiesmann, Christian
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 28.11.2007
Blackwell Publishing Ltd
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neuropilins (Nrps) are co‐receptors for class 3 semaphorins and vascular endothelial growth factors and important for the development of the nervous system and the vasculature. The extracellular portion of Nrp is composed of two domains that are essential for semaphorin binding (a1a2), two domains necessary for VEGF binding (b1b2), and one domain critical for receptor dimerization (c). We report several crystal structures of Nrp1 and Nrp2 fragments alone and in complex with antibodies that selectively block either semaphorin or vascular endothelial growth factor (VEGF) binding. In these structures, Nrps adopt an unexpected domain arrangement in which the a2, b1, and b2 domains form a tightly packed core that is only loosely connected to the a1 domain. The locations of the antibody epitopes together with in vitro experiments indicate that VEGF and semaphorin do not directly compete for Nrp binding. Based upon our structural and functional data, we propose possible models for ligand binding to neuropilins.
Bibliography:Supplementary Figure S1-S8
ArticleID:EMBJ7601906
ark:/67375/WNG-BTRV2T64-C
istex:AB5729DC76EAF891407A74B81AF7C8627DDA7FFB
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Lilly Corporate Center, Indianapolis, IN 46285, USA
ISSN:0261-4189
1460-2075
DOI:10.1038/sj.emboj.7601906